Pharma Mar (OTCMKTS:PHMMF – Get Free Report) shares shot up 4.6% during trading on Friday . The stock traded as high as $90.21 and last traded at $90.21. 174 shares were traded during mid-day trading, an increase of 1,844% from the average session volume of 9 shares. The stock had previously closed at $86.26.
Pharma Mar Price Performance
The stock’s fifty day simple moving average is $87.28 and its 200-day simple moving average is $92.78. The company has a current ratio of 2.84, a quick ratio of 2.25 and a debt-to-equity ratio of 0.19.
About Pharma Mar
PharmaMar is a Spain-based biopharmaceutical company that specializes in the discovery and development of novel oncology therapies derived from marine organisms. Founded in 1986 as part of Grupo Zeltia, the company has pioneered the use of compounds extracted from deep-sea organisms to create synthetic analogs aimed at treating various forms of cancer. Its core expertise lies in marine biotechnology, medicinal chemistry and oncology-focused clinical development.
The company’s flagship product is Yondelis (trabectedin), an antitumor agent approved in the European Union for the treatment of soft tissue sarcoma and relapsed platinum-sensitive ovarian cancer.
Featured Articles
- Five stocks we like better than Pharma Mar
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- Best $19 you’ll spend this year.
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
